Business Wire

insitro Partners with Lilly to Build First-in-Kind Machine Learning Models to Advance Small Molecule Drug Discovery

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
Morning Overview on MSN

This cancer-fighting molecule took 50 years to build

The story of a cancer-fighting molecule that took half a century to build is really a story about how slow, stubborn ...
Morningstar

Genesis Molecular AI Unveils Pearl, a Field-Leading Foundation Model that Achieves Unprecedented Performance in Drug-Protein Structure Prediction

Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...